Chlorthalidone tablets are typically white, round, and may bear imprint codes indicating strength (e.g., “6.25” or “12.5”). The exact markings can vary by manufacturer, so checking the packaging label is advisable.
Chlorthalidone is not a prohibited substance in most sports doping lists, but its diuretic effect can be flagged as a masking agent. Athletes should disclose any prescription diuretics to their anti-doping organization.
Both act on the distal tubule, but chlorthalidone has a longer half-life and greater potency per milligram, often providing more sustained blood-pressure control with fewer daily doses.
No, chlorthalidone is a prescription-only medication in the UK and most other jurisdictions because of its potential for serious electrolyte disturbances.
Dispose of them according to local pharmacy take-back programs or via the NHS Medicine Disposal Service. Do not flush tablets down the toilet unless instructed otherwise.
Yes, but keep the medication in its original labeled container, carry a copy of the prescription, and be aware of destination-specific customs regulations for prescription drugs.
Lower doses are often started in elderly patients, those with mild hypertension, or individuals prone to electrolyte loss, allowing clinicians to gauge tolerance before increasing the dose.
It can modestly raise blood glucose, especially in patients with pre-existing diabetes or impaired glucose tolerance; regular monitoring is recommended.
Chlorthalidone is mainly marketed under its generic name, though some manufacturers may use brand variations; the product label will always list “chlorthalidone” as the active ingredient.
Blood-pressure reduction can be observed within a few days, but the maximal effect may take several weeks of consistent dosing.
Chlorthalidone is a thiazide-like diuretic used to lower blood pressure and reduce fluid retention. It is supplied as a pill in strengths of 6.25 mg and 12.5 mg. In the United Kingdom, chlorthalidone is a prescription-only medicine regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
These uses are approved by the MHRA and reflect the drug’s classification as a heart- and blood-pressure medication.
This article provides educational information about chlorthalidone and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.